References
- Pasquini MC, Wang Z, Horowitz M, Gale RP. 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplant for blood and bone marrow disorders. In: , Cecka J M, Terazaki P I, ed, editors. Clinical transplants 2010. Los Angeles (CA): The Terasaki Foundation Laboratory; 2011. p. 87–105.
- Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A. Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol. 2002;117(2):451–68.
- Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al.. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303(16):1617–24.
- Ruiz-Arguelles GJ. Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: results of the Mexican approach. Int J Hematol. 2002;76 Suppl 1:376–9.
- Ruiz-Arguelles GJ, Gomez-Almaguer D, Morales-Toquero A, Gutierrez-Aguirre CH, Vela-Ojeda J, Garcia-Ruiz-Esparza MA, et al.. The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter study. Bone Marrow Transplant. 2005;36(12):1043–7.
- Hamerschlak N, Maluf E, Pasquini R, Eluf-Neto J, Moreira FR, Cavalcanti AB, et al.. Incidence of aplastic anemia and agranulocytosis in Latin America — the LATIN study. Sao Paulo Med J. 2005;123(3):101–4.
- Maluf EM, Pasquini R, Eluf JN, Kelly J, Kaufman DW. Aplastic anemia in Brazil: incidence and risk factors. Am J Hematol. 2002;71(4):268–74.
- Maluf E, Hamerschlak N, Cavalcanti AB, Junior AA, Eluf-Neto J, Falcao RP, et al.. Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study. Haematologica. 2009;94(9):1220–6.
- Bonfim CM, de Medeiros CR, Bitencourt MA, Zanis-Neto J, Funke VA, Setubal DC, et al.. HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. Biol Blood Marrow Transplant. 2007;13(12):1455–60.
- Yates J, Keeble W, Pals G, Ameziane N, van Spaendonk R, Olson S, et al.. Novel inactivating mutations of FANCC in Brazilian patients with Fanconi anemia. Hum Mutat. 2006;27(2):214.